ICP-1

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameICP-1
Drug Alias Nameindolocarbazole derivative (Dartmouth Medical School)ICP-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell cycle inhibitors
TargetsUpdating
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDartmouth Medical School
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDartmouth Medical School
Active IndicationsN/A
Inactive IndicationsSolid tumoursNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A